In some cancers, FN expression can act as a tumor suppressor, as observed in tyrosine kinase receptor Met and its ligand, hepatocyte growth factor (HGF)/scatter factor-mediated tumorigenesis (Taylor et al., 1998). The gene discussed is FN1; the disease is neoplasm.